13-cis-Retinoic acid with α-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2277-2280

  DeLaney, Thomas F ^a   Afridi, Nadeem ^a   Taghian, Alphonse G ^a   Sanders, Dennis A ^a   Fuleihan, Nabil S ^a   Faller, Douglas V ^a   Nogueira, Christine P ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ISOTRETINOIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DRUG EFFICACY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; HEAD AND NECK NEOPLASMS; HUMANS; INTERFERON ALFA-2A; ISOTRETINOIN; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0029967343     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wingo, P. A., Tong, T., and Bolden, S Cancer statistics, 1995. CA Cancer J. Clin., 45. 8-31, 1995
2. Vokes, E. E., Weichselbaum, R R , Lippman, S M., and Hong, W. K Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
3. Horiot, J. C , LeFur, R., N'Guyen, T., Chenal, C., Schraub, S., Alfonsi, S., Gardani, G , Van Den Bogaert, W., Danczak, S., Bolla, M , Van Glabbeke, M., and De Pauw, M. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy Radiother Oncol , 25 231-241, 1992.
4. Dritschillo, A., Mossman, K , Gray, M , and Sreevalsan, T. Potentiation of radiation injury by interferon. Am. J. Clin. Oncol., 5: 79-82, 1982
5. Kardamakis, D., Gillies, N E., Souhami, R. L , and Bewerley, P. C L. Recombinant human interferon α-2b enhances the radiosensitivity of small cell lung cancer in vitro. Anticancer Res., 9: 1041-1044, 1989.
6. 2-M phase of the cell cycle. Cancer Res., 47: 4338-4341, 1987.
7. Angioli, R., Sevin, B., Perras, J P., Untch, M , Koechli, O. R., Nguyen, H. N., Steren, A., Schwade, J. G., Villani, C., and Averette, H. E. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines. Cancer (Phila), 71: 3717-3725, 1993.
8. Lotan R Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem. Biophys Acta 605. 33-91, 1980.
9. Hong, W. K , Lippman, S. M , Itri, L M , Karp, D D , Lee, J. S , Byers, R. M , Schantz, S. P., Kramer, A. M , Lotan, R., Peters, L. J., Dimery, I. W., Brown, B W , and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl J Med , 323: 795-801, 1990
10. Rutz, H. P., and Little, J. B. Modification of radiosensitivity and recovery from x ray damage in vitro by retinoic acid. Int J. Radiat. Oncol. Biol. Phys , 16. 1285-1288, 1989.
11. Lippman, S. M., Batsakis, J. G., Toth, B. B., Weber, R. S., Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, K., and Hong, W. K. Comparison of low-dose isotretinoin with β carotene to prevent oral carcinogenesis. N. Engl. J. Med., 328: 15-20, 1993.
12. Brazzell, R. K., and Colburn, W. A. Pharmacokinetics of the retinoids isotretinoin and etretinate. J. Am. Acad. Dermatol , 6: 643-651, 1982.
13. Frey, J. R., Peck, R., and Bollag, W. Antiproliferative activity of retinoids, interferon a and their combination in five human transformed cell lines. Cancer Lett., 57: 223-227, 1991.
14. Fertil, B., Dertinger, H , Courdi, A., and Malaise, E. P. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat. Res., 99: 73-84, 1984.
15. Hall, E. J. Radiobiology for the Radiobiologist, pp. 17-38. Philadelphia: J. B. Lippincott Co., 1988.
16. Lippman, S. M., Kavanagh, J J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Massimini, G., Holdener, E. E., and Krakoff, I. H. 13-cis-Retinoic acid plus interferon-α2a for locally advanced squamous cell carcinoma of the cervix. J. Natl Cancer Inst , 85: 499-500, 1993.
17. Lippman, S. M., Kavanagh, J. J., Paredes, M., Delgadillo, F., Hoog, W. K., Figuerda, F., Olguin, A., Freedman, R. S., Massimini, G., Holdener, E. E., and Krakoff, I. H. 13-cis-retinoic acid (13 cRA), interferon-α2a and radiotherapy for locally advanced cancer of the cervix. Proc. Am. Soc. Clin. Oncol. Annu. Meet. 12. 257, 1993.
18. Valavaara, R., Kortekangas, A. E., Nordman, E., and Cantell, K. Interferon combined with irradiation in the treatment of operable head and neck carcinoma: a pilot study. Acta Oncol., 31: 429-431, 1992.
19. Mason, K. A , and Tofilon, P. J. Unexpected radiation protection with 13-cis-retinoic acid plus interferon α-2a. Cancer Chemother. Pharmacol., 33: 435-437, 1994.
20. Hoffman, W., Kley, I., Schiller, U., Schlak, I., Bamberg, M., and Rodemann, H. P. Retinoids and interferon-α enhance the antiproliferative effect of radiation in cultured human squamous cell carcinoma lines. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 14: 513, 1995.